Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
April 2, 2025
Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma
Hiroaki Takaya, Tadashi Namisaki, Yusuke Komeda, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 28, 2023
Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B
Misako Tanaka, Takemi Akahane, Hideto Kawaratani, et al.
World Journal of Gastrointestinal Oncology
|
October 31, 2019
Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 5, 2024
Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus-related liver cirrhosis
Satoshi Iwai, Takemi Akahane, Hiroaki Takaya, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Association between Equol Production Status and Nonalcoholic Steatohepatitis
Takemi Akahane, Daisuke Kaya, Ryuichi Noguchi, et al.
In Vivo (Athens, Greece)
|
April 28, 2022
Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy
Tadashi Namisaki, Yuki Tsuji, Mitsuteru Kitade, et al.
Antibiotics (Basel, Switzerland)
|
April 3, 2020
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
Kosuke Kaji, Soichiro Saikawa, Hiroaki Takaya, et al.
Anticancer Research
|
September 26, 2025
The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma
Soichi Takeda, Tadashi Namisaki, Aritoshi Koizumi, et al.
Anticancer Research
|
October 26, 2022
Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
Soichi Takeda, Tadashi Namisaki, Yuki Tsuji, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
April 2, 2025
Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma
Hiroaki Takaya, Tadashi Namisaki, Yusuke Komeda, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 28, 2023
Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B
Misako Tanaka, Takemi Akahane, Hideto Kawaratani, et al.
World Journal of Gastrointestinal Oncology
|
October 31, 2019
Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 5, 2024
Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus-related liver cirrhosis
Satoshi Iwai, Takemi Akahane, Hiroaki Takaya, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Association between Equol Production Status and Nonalcoholic Steatohepatitis
Takemi Akahane, Daisuke Kaya, Ryuichi Noguchi, et al.
In Vivo (Athens, Greece)
|
April 28, 2022
Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy
Tadashi Namisaki, Yuki Tsuji, Mitsuteru Kitade, et al.
Antibiotics (Basel, Switzerland)
|
April 3, 2020
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
Kosuke Kaji, Soichiro Saikawa, Hiroaki Takaya, et al.
Anticancer Research
|
September 26, 2025
The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma
Soichi Takeda, Tadashi Namisaki, Aritoshi Koizumi, et al.
Anticancer Research
|
October 26, 2022
Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
Soichi Takeda, Tadashi Namisaki, Yuki Tsuji, et al.
Page
of 11